Pomalidomide Could Become Leading Drug in HHT Care

Pomalidomide Could Become Leading Drug in HHT Care

User Photo
ASHReport

4 years
1,088 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Keith McCrae, MD of Cleveland Clinic gives his view on pomalidomide in HHT care at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>